Aspen Pharmacare Holdings Limited (JSE:APN)

South Africa flag South Africa · Delayed Price · Currency is ZAR · Price in ZAc
12,389
+289 (2.39%)
Jul 29, 2025, 5:08 PM SAST
2.39%
Market Cap53.75B
Revenue (ttm)45.53B
Net Income (ttm)4.48B
Shares Out444.21M
EPS (ttm)10.08
PE Ratio12.00
Forward PE10.45
Dividend3.59 (2.97%)
Ex-Dividend DateSep 18, 2024
Volume2,988,552
Average Volume1,322,733
Open12,100
Previous Close12,100
Day's Range12,100 - 12,720
52-Week Range10,575 - 25,296
Beta0.42
RSI62.93
Earnings DateSep 3, 2025

About Aspen Pharmacare Holdings

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counte... [Read more]

Sector Healthcare
Founded 1850
Employees 9,350
Stock Exchange Johannesburg Stock Exchange
Ticker Symbol APN
Full Company Profile

Financial Performance

In 2024, Aspen Pharmacare Holdings's revenue was 44.71 billion, an increase of 9.82% compared to the previous year's 40.71 billion. Earnings were 4.40 billion, a decrease of -15.76%.

Financial Statements

News

One of South Africa’s richest men lost R1.7 billion in a day

Aspen Pharmacare CEO Stephen Saad lost an estimated R1.68 billion on Tuesday due to a sharp decline in the company's share price following disappointing financial results.

11 months ago - Daily Investor

Aspen Pharmacare Holdings Limited (APNHF) Q2 2024 Earnings Call Transcript

Aspen Pharmacare Holdings Limited (APNHF) Q2 2024 Earnings Call Transcript

1 year ago - Seeking Alpha

South Africa's Aspen Pharmacare to buy Sandoz's China business

Aspen Pharmacare will buy the Chinese business of Swiss group Sandoz , including commercialisation rights and intellectual property for some established products and those in the pipeline, for up to 9...

1 year ago - Reuters

Aspen Pharmacare Holdings Limited (APNHF) Q4 2023 Earnings Call Transcript

Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2023 Results Conference Call August 31, 2023 2:30 AM ET Company Participants Sibongakonke N. - Investor Relations Manager Stephen Saad - Chief Execut...

2 years ago - Seeking Alpha

Aspen Pharmacare Holdings Limited (APNHF) H1 2023 Earnings Call Transcript

Aspen Pharmacare Holdings Limited (OTCPK:APNHF) H1 2023 Earnings Conference Call March 2, 2023 1:30 AM ET Company Participants Stephen Saad – Chief Executive Officer Sean Capazorio – Chief Financial O...

2 years ago - Seeking Alpha

Aspen Pharmacare Holdings Limited (APNHF) Q4 2022 Earnings Call Transcript

Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2022 Earnings Conference Call September 1, 2022 2:30 AM ET Company Participants Kuseni Dlamini - Chairman Sean Capazorio - Group Chief Financial Offi...

3 years ago - Seeking Alpha

Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Interim 2022 Results - Earnings Call Transcript

Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Interim 2022 Results - Earnings Call Transcript

3 years ago - Seeking Alpha

Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Q4 2021 Results - Earnings Call Transcript

Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Q4 2021 Results - Earnings Call Transcript

4 years ago - Seeking Alpha

Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad Presents H1 2021 Results at JP Morgan Healthcare Conference (Transcript)

Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad Presents H1 2021 Results at JP Morgan Healthcare Conference (Transcript)

4 years ago - Seeking Alpha

Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Q4 2020 Results - Earnings Call Transcript

Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Q4 2020 Results - Earnings Call Transcript

5 years ago - Seeking Alpha